BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 22093959)

  • 1. Bone and mineral metabolism and fibroblast growth factor 23 levels after kidney donation.
    Young A; Hodsman AB; Boudville N; Geddes C; Gill J; Goltzman D; Jassal SV; Klarenbach S; Knoll G; Muirhead N; Prasad GV; Treleaven D; Garg AX;
    Am J Kidney Dis; 2012 Jun; 59(6):761-9. PubMed ID: 22093959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fracture risk in living kidney donors: a matched cohort study.
    Garg AX; Pouget J; Young A; Huang A; Boudville N; Hodsman A; Adachi JD; Leslie WD; Cadarette SM; Lok CE; Monroy-Cuadros M; Prasad GV; Thomas SM; Naylor K; Treleavan D;
    Am J Kidney Dis; 2012 Jun; 59(6):770-6. PubMed ID: 22472209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.
    Sánchez Fructuoso AI; Maestro ML; Pérez-Flores I; Valero R; Rafael S; Veganzones S; Calvo N; De la Orden V; De la Flor JC; Valga F; Vidaurreta M; Fernández-Pérez C; Barrientos A
    Nephrol Dial Transplant; 2012 Nov; 27(11):4227-35. PubMed ID: 23144073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of living kidney donors over the past 28 years in a single center in Taiwan.
    Tsai SF; Shu KH; Ho HC; Wu MJ; Cheng CH; Lian JD; Wen MC; Su CK; Yu TM; Chuang YW; Huang ST; Chen CH
    Transplant Proc; 2012 Jan; 44(1):39-42. PubMed ID: 22310573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-nephrectomy development of renal function in living kidney donors: a cross-sectional retrospective study.
    Fehrman-Ekholm I; Kvarnström N; Söfteland JM; Lennerling A; Rizell M; Odén A; Simonsson T
    Nephrol Dial Transplant; 2011 Jul; 26(7):2377-81. PubMed ID: 21459783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.
    Gutierrez O; Isakova T; Rhee E; Shah A; Holmes J; Collerone G; Jüppner H; Wolf M
    J Am Soc Nephrol; 2005 Jul; 16(7):2205-15. PubMed ID: 15917335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation.
    Sánchez Fructuoso AI; Maestro ML; Calvo N; De La Orden V; Pérez Flores I; Vidaurreta M; Valero R; Fernández-Pérez C; Barrientos A
    Transplant Proc; 2012 Nov; 44(9):2551-4. PubMed ID: 23146451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral disorders in pediatric and adolescent renal transplant recipients.
    Derakhshan A; Behbahan AG; Lotfi M; Omrani GH; Fallahzadeh MH; Basiratnia M; Al-Hashemi GH
    Pediatr Transplant; 2011 Jun; 15(4):367-75. PubMed ID: 21429060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective controlled study of living kidney donors: three-year follow-up.
    Kasiske BL; Anderson-Haag T; Israni AK; Kalil RS; Kimmel PL; Kraus ES; Kumar R; Posselt AA; Pesavento TE; Rabb H; Steffes MW; Snyder JJ; Weir MR
    Am J Kidney Dis; 2015 Jul; 66(1):114-24. PubMed ID: 25795073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of long-term risks for living related kidney donors by 24-h blood pressure monitoring and testing for microalbuminuria.
    Eberhard OK; Kliem V; Offner G; Oldhafer K; Fangmann J; Pichlmay R; Koch KM; Brunkhorst R
    Clin Transplant; 1997 Oct; 11(5 Pt 1):415-9. PubMed ID: 9361933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and long term mineral metabolism adaptation in living kidney donors: a prospective study.
    Ponte B; Trombetti A; Hadaya K; Ernandez T; Fumeaux D; Iselin C; Martin PY; de Seigneux S
    Bone; 2014 May; 62():36-42. PubMed ID: 24495507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
    Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.
    Tomida K; Hamano T; Ichimaru N; Fujii N; Matsui I; Nonomura N; Tsubakihara Y; Rakugi H; Takahara S; Isaka Y
    Bone; 2012 Oct; 51(4):729-36. PubMed ID: 22796419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
    Fahrleitner A; Prenner G; Kniepeiss D; Iberer F; Tscheliessnigg KH; Piswanger-Sölkner C; Obermayer-Pietsch B; Leb G; Dobnig H
    Wien Klin Wochenschr; 2002 Aug; 114(15-16):717-24. PubMed ID: 12602117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definition of chronic kidney disease after uninephrectomy in living donors: what are the implications?
    Barri YM; Parker T; Daoud Y; Glassock RJ
    Transplantation; 2010 Sep; 90(5):575-80. PubMed ID: 20562736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do multiple renal arteries in the remnant kidney have a negative influence on kidney donors after kidney donation?
    Ma LL; Li G; Huang Y; Hou XF; Zhao L; Wang GL; Tang WH; Chen YT
    Nephrology (Carlton); 2011 Aug; 16(6):612-6. PubMed ID: 21676070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal outcome 25 years after donor nephrectomy.
    Goldfarb DA; Matin SF; Braun WE; Schreiber MJ; Mastroianni B; Papajcik D; Rolin HA; Flechner S; Goormastic M; Novick AC
    J Urol; 2001 Dec; 166(6):2043-7. PubMed ID: 11696703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The safety analysis of living-related kidney donors in short term after transplantation].
    Zhao YB; Shi BY; Chen Z; Pan GH; Liao DH; Fang JL; Wang K; Gao ZL
    Zhonghua Wai Ke Za Zhi; 2009 Sep; 47(17):1316-8. PubMed ID: 20092727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Older living donors provide excellent quality kidneys: a single center experience (older living donors).
    Johnson SR; Khwaja K; Pavlakis M; Monaco AP; Hanto DW
    Clin Transplant; 2005 Oct; 19(5):600-6. PubMed ID: 16146550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men.
    Mirza MA; Karlsson MK; Mellström D; Orwoll E; Ohlsson C; Ljunggren O; Larsson TE
    J Bone Miner Res; 2011 Apr; 26(4):857-64. PubMed ID: 20928885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.